How to buy Panacea Acquisition CorpII stock - 21 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Panacea Acquisition CorpII stock

Own Panacea Acquisition CorpII stock in just a few minutes.

Panacea Acquisition Corp. II is a shell companies business based in the US. Panacea Acquisition CorpII shares (PANA) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Panacea Acquisition CorpII

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PANA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Panacea Acquisition CorpII share price

Use our graph to track the performance of PANA stocks over time.

Panacea Acquisition CorpII shares at a glance

Information last updated 2021-04-16.
52-week range$9.25 - $14.97
50-day moving average $10.00
200-day moving average $10.00
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Panacea Acquisition CorpII shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Panacea Acquisition CorpII stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Panacea Acquisition CorpII financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $205 million

TTM: trailing 12 months

Shorting Panacea Acquisition CorpII shares

There are currently 13,901 Panacea Acquisition CorpII shares held short by investors – that's known as Panacea Acquisition CorpII's "short interest". This figure is 63.3% down from 37,827 last month.

There are a few different ways that this level of interest in shorting Panacea Acquisition CorpII shares can be evaluated.

Panacea Acquisition CorpII's "short interest ratio" (SIR)

Panacea Acquisition CorpII's "short interest ratio" (SIR) is the quantity of Panacea Acquisition CorpII shares currently shorted divided by the average quantity of Panacea Acquisition CorpII shares traded daily (recently around 463366.66666667). Panacea Acquisition CorpII's SIR currently stands at 0.03. In other words for every 100,000 Panacea Acquisition CorpII shares traded daily on the market, roughly 30 shares are currently held short.

However Panacea Acquisition CorpII's short interest can also be evaluated against the total number of Panacea Acquisition CorpII shares, or, against the total number of tradable Panacea Acquisition CorpII shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Panacea Acquisition CorpII's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Panacea Acquisition CorpII shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Panacea Acquisition CorpII shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Panacea Acquisition CorpII.

Find out more about how you can short Panacea Acquisition CorpII stock.

Panacea Acquisition CorpII share dividends

We're not expecting Panacea Acquisition CorpII to pay a dividend over the next 12 months.

Panacea Acquisition CorpII overview

Panacea Acquisition Corp. II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site